AAPL 250.9362 1.1636% MSFT 439.85 0.5624% NVDA 132.26 2.5987% GOOGL 190.36 1.0403% GOOG 191.585 0.7547% AMZN 224.7026 1.8967% META 605.1 1.3245% AVGO 221.57 -0.9167% TSLA 434.8 -1.211% TSM 195.3 -0.133% LLY 758.87 -0.7637% V 315.9 1.9756% JPM 234.325 1.7168% UNH 493.79 -1.1867% NVO 103.7 -2.1329% WMT 93.89 0.3634% LVMUY 130.52 0.7721% XOM 105.67 -0.7048% LVMHF 649.5 0.6649% MA 526.755 1.3068%
Last update at 2024-12-19T18:53:00Z
Pricing to Aid CL's Q3 Earnings: Should Investors Take Advantage?
Mon 21 Oct 24, 02:23 PMPhilip Morris' Q3 Earnings Coming Up: Here's What You Should Know
Fri 18 Oct 24, 02:42 PMKimberly-Clark's Q3 Earnings Coming Up: Here's What You Should Know
Fri 18 Oct 24, 01:56 PMSlowing Rates Of Return At Colgate-Palmolive (NYSE:CL) Leave Little Room For Excitement
Thu 17 Oct 24, 12:00 PMOil prices slide on weak China inflation, disappointing stimulus
Mon 14 Oct 24, 12:21 AMWhat are the chances for an escalation in the Middle East over the next 6-9 months
Sun 13 Oct 24, 09:40 AMIs Colgate-Palmolive Company (CL) the Best Safe Stock To Invest In For The Long Term in 2024?
Sat 12 Oct 24, 01:41 PMAre Investors Undervaluing Colgate-Palmolive Company (NYSE:CL) By 33%?
Sat 12 Oct 24, 12:00 PM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 2660.00M | 3087.00M | 3647.00M | 3301.00M | 3464.00M |
| Minority interest | -182.00000M | -172.00000M | 165.00M | 160.00M | 158.00M |
| Net income | 1785.00M | 2166.00M | 2695.00M | 2367.00M | 2400.00M |
| Selling general administrative | 6560.00M | 4410.00M | 6019.00M | 5575.00M | 5389.00M |
| Selling and marketing expenses | - | 1997.00M | - | - | - |
| Gross profit | 10248.00M | 10375.00M | 10017.00M | 9325.00M | 9231.00M |
| Reconciled depreciation | 545.00M | 556.00M | 539.00M | 519.00M | 511.00M |
| Ebit | 4335.00M | 4474.00M | 3885.00M | 3554.00M | 3694.00M |
| Ebitda | 4880.00M | 5030.00M | 4424.00M | 4073.00M | 4205.00M |
| Depreciation and amortization | 545.00M | 556.00M | 539.00M | 519.00M | 511.00M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 4335.00M | 4474.00M | 3885.00M | 3554.00M | 3694.00M |
| Other operating expenses | 14353.00M | 13518.00M | 12586.00M | 12139.00M | 11850.00M |
| Interest expense | 167.00M | 192.00M | 183.00M | 192.00M | 193.00M |
| Tax provision | 693.00M | 749.00M | 787.00M | 774.00M | 906.00M |
| Interest income | 153.00M | 175.00M | 164.00M | 47.00M | 50.00M |
| Net interest income | -153.00000M | -175.00000M | -164.00000M | -145.00000M | -143.00000M |
| Extraordinary items | - | - | - | - | -80.00000M |
| Non recurring | 721.00M | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 693.00M | 749.00M | 787.00M | 774.00M | 906.00M |
| Total revenue | 17967.00M | 17421.00M | 16471.00M | 15693.00M | 15544.00M |
| Total operating expenses | 6634.00M | 6472.00M | 6132.00M | 5771.00M | 5537.00M |
| Cost of revenue | 7719.00M | 7046.00M | 6454.00M | 6368.00M | 6313.00M |
| Total other income expense net | -1675.00000M | -1387.00000M | -238.00000M | -253.00000M | -87.00000M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 1967.00M | 2338.00M | 2860.00M | 2527.00M | 2558.00M |
| Net income applicable to common shares | 1785.00M | 2166.00M | 2695.00M | 2367.00M | 2400.00M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 16393.00M | 15731.00M | 15040.00M | 15920.00M | 15034.00M |
| Intangible assets | 1887.00M | 1920.00M | 2462.00M | 2894.00M | 2667.00M |
| Earning assets | - | - | - | - | - |
| Other current assets | 614.00M | 760.00M | 576.00M | 513.00M | 456.00M |
| Total liab | 15436.00M | 14925.00M | 14069.00M | 14819.00M | 14476.00M |
| Total stockholder equity | 609.00M | 401.00M | 609.00M | 743.00M | 117.00M |
| Deferred long term liab | - | 383.00M | 395.00M | 426.00M | 507.00M |
| Other current liab | 2282.00M | 2295.00M | 4000.00M | 4137.00M | 3524.00M |
| Common stock | 1466.00M | 1466.00M | 1466.00M | 1466.00M | 1466.00M |
| Capital stock | 1466.00M | 1466.00M | 1466.00M | 1466.00M | 1466.00M |
| Retained earnings | 25289.00M | 24573.00M | 24350.00M | 23699.00M | 22501.00M |
| Other liab | - | 1783.00M | 2824.00M | 3081.00M | 2614.00M |
| Good will | 3410.00M | 3352.00M | 3284.00M | 3824.00M | 3508.00M |
| Other assets | - | 1039.00M | 1167.00M | 1.15M | 374.00M |
| Cash | 966.00M | 775.00M | 832.00M | 888.00M | 883.00M |
| Cash and equivalents | - | 775.00M | 832.00M | 888.00M | 883.00M |
| Total current liabilities | 4741.00M | 3979.00M | 4000.00M | 4137.00M | 11371.00M |
| Current deferred revenue | 1410.00M | - | -1667.00000M | -1797.00000M | -1237.00000M |
| Net debt | 8098.00M | 8124.00M | 6413.00M | 6713.00M | 6964.00M |
| Short term debt | 425.00M | 133.00M | 188.00M | 404.00M | 7847.00M |
| Short long term debt | 330.00M | 25.00M | 51.00M | 267.00M | 514.00M |
| Short long term debt total | 9064.00M | 8899.00M | 7245.00M | 7601.00M | 7847.00M |
| Other stockholder equity | -22209.00000M | -21583.00000M | -20821.00000M | -20077.00000M | -19577.00000M |
| Property plant equipment | - | 4307.00M | 3730.00M | 3716.00M | 3750.00M |
| Total current assets | 5279.00M | 5113.00M | 4397.00M | 4338.00M | 4179.00M |
| Long term investments | - | - | - | - | 54.00M |
| Net tangible assets | - | -4871.00000M | -5137.00000M | -5975.00000M | 117.00M |
| Short term investments | 179.00M | 175.00M | 34.00M | 37.00M | 23.00M |
| Net receivables | 1586.00M | 1504.00M | 1297.00M | 1264.00M | 1440.00M |
| Long term debt | 8219.00M | 8766.00M | 7245.00M | 7334.00M | 7333.00M |
| Inventory | 1934.00M | 2074.00M | 1692.00M | 1673.00M | 1400.00M |
| Accounts payable | 1698.00M | 1551.00M | 1479.00M | 1393.00M | 1237.00M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | 405.00M | 362.00M | 358.00M | 441.00M |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -3937.00000M | -4055.00000M | -4386.00000M | -4345.00000M | -4273.00000M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | 1466.00M | 1466.00M | 1466.00M | 1466.00M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | 24573.00M | 24350.00M | 23699.00M | 22501.00M |
| Treasury stock | - | - | -24089.00000M | -23045.00000M | -22063.00000M |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 447.00M | 904.00M | 1167.00M | 1148.00M | 930.00M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 11114.00M | 10618.00M | 10643.00M | 11582.00M | 10855.00M |
| Capital lease obligations | 515.00M | 505.00M | 588.00M | 613.00M | 636.00M |
| Long term debt total | - | 8766.00M | 7245.00M | 7334.00M | 7333.00M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | -772.00000M | -1601.00000M | -592.00000M | -19.00000M | -53.00000M |
| Change to liabilities | - | -115.00000M | 14.00M | 520.00M | 36.00M |
| Total cashflows from investing activities | - | -1601.00000M | -592.00000M | -779.00000M | -2099.00000M |
| Net borrowings | - | 1647.00M | -175.00000M | -564.00000M | 1448.00M |
| Total cash from financing activities | -2793.00000M | -952.00000M | -2774.00000M | -2919.00000M | -870.00000M |
| Change to operating activities | - | -51.00000M | -55.00000M | -26.00000M | 87.00M |
| Net income | 2300.00M | 1967.00M | 2338.00M | 2860.00M | 2527.00M |
| Change in cash | 191.00M | -57.00000M | -56.00000M | 5.00M | 157.00M |
| Begin period cash flow | 775.00M | 832.00M | 888.00M | 883.00M | 726.00M |
| End period cash flow | 966.00M | 775.00M | 832.00M | 888.00M | 883.00M |
| Total cash from operating activities | 3745.00M | 2556.00M | 3325.00M | 3719.00M | 3133.00M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 567.00M | 545.00M | 556.00M | 539.00M | 519.00M |
| Other cashflows from investing activities | - | -905.00000M | -25.00000M | -350.00000M | -1711.00000M |
| Dividends paid | 1749.00M | 1691.00M | 1679.00M | 1654.00M | 1614.00M |
| Change to inventory | 194.00M | -333.00000M | -72.00000M | -251.00000M | -77.00000M |
| Change to account receivables | -37.00000M | -227.00000M | -84.00000M | 138.00M | 19.00M |
| Sale purchase of stock | -1128.00000M | -1308.00000M | -1320.00000M | -1476.00000M | -1202.00000M |
| Other cashflows from financing activities | 398.00M | 2453.00M | -24.00000M | -99.00000M | 8557.00M |
| Change to netincome | - | 770.00M | 800.00M | -61.00000M | 22.00M |
| Capital expenditures | 705.00M | 696.00M | 567.00M | 410.00M | 335.00M |
| Change receivables | - | -227.00000M | -84.00000M | 138.00M | 19.00M |
| Cash flows other operating | - | -51.00000M | -55.00000M | -26.00000M | 87.00M |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | 3.00M | -41.00000M | 21.00M | 164.00M |
| Change in working capital | 455.00M | -726.00000M | -197.00000M | 381.00M | 65.00M |
| Stock based compensation | 122.00M | 125.00M | 135.00M | 107.00M | 100.00M |
| Other non cash items | 399.00M | 723.00M | 625.00M | -48.00000M | -95.00000M |
| Free cash flow | 3040.00M | 1860.00M | 2758.00M | 3309.00M | 2798.00M |
Sector: Consumer Defensive Industry: Household & Personal Products
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CL Colgate-Palmolive Company |
0.70 0.75% | 93.45 | 26.98 | 24.15 | 3.82 | 174.56 | 4.13 | 18.16 |
| PG Procter & Gamble Company |
0.91 0.54% | 169.99 | 23.58 | 22.62 | 4.07 | 7.24 | 4.40 | 16.08 |
| LRLCF L'Oréal S.A |
0.16 0.05% | 350.36 | 41.14 | 34.25 | 6.52 | 8.59 | 6.67 | 27.76 |
| LRLCY L’Oreal Co ADR |
0.64 0.92% | 70.40 | 41.27 | 33.90 | 6.56 | 8.50 | 6.65 | 27.67 |
| UNLYF Unilever PLC |
-1.0 1.69% | 58.25 | 21.17 | 17.33 | 2.44 | 6.76 | 2.66 | 12.91 |
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, and Soupline to a range of traditional and eCommerce retailers, wholesalers, and distributors. It includes pharmaceutical products for dentists and other oral health professionals. Its Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
300 Park Avenue, New York, NY, United States, 10022-7499
| Name | Title | Year Born |
|---|---|---|
| Mr. Noel R. Wallace | Chairman, CEO & Pres | 1964 |
| Mr. Stanley J. Sutula III | Chief Financial Officer | 1966 |
| Ms. Jennifer M. Daniels | Chief Legal Officer & Sec. | 1964 |
| Mr. Panagiotis Tsourapas | Group Pres of Europe & Developing Markets | 1965 |
| Ms. Prabha Parameswaran | Group Pres of Growth & Strategy | 1959 |
| Mr. Gregory Malcolm | VP, Controller & Principal Accounting Officer | 1967 |
| Mr. Stephan Habif | Chief Technology Officer | NA |
| Mr. Mike Crowe | Chief Information Officer | NA |
| John Faucher | Chief Investor Relations Officer | NA |
| Valerie Haliburton | VP of Global Ethics & Compliance | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
US 
AU
UK
CA
NZ
Please wait processing your request...